Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation

被引:2
作者
Richter, Patricia [1 ]
Badescu, Minerva Codruta [2 ,3 ]
Rezus, Ciprian [2 ,3 ]
Ouatu, Anca [2 ,3 ]
Dima, Nicoleta [2 ,3 ]
Popescu, Diana [2 ]
Burlui, Alexandra Maria [1 ,4 ]
Bratoiu, Ioana [1 ,4 ]
Mihai, Ioana Ruxandra [1 ,4 ]
Rezus, Elena [1 ,4 ]
机构
[1] Grigore T Popa Univ Med & Pharm, Dept Rheumatol & Physiotherapy, 16 Univ St, Iasi 700115, Romania
[2] Grigore T Popa Univ Med & Pharm, Dept Internal Med, 16 Univ St, Iasi 700115, Romania
[3] St Spiridon Cty Emergency Clin Hosp, IIIrd Internal Med Clin, 1 Independence Blvd, Iasi 700111, Romania
[4] Clin Rehabil Hosp, Rheumatol Clin 1, 14 Pantelimon Halipa St, Iasi 700661, Romania
关键词
systemic lupus erythematosus; antiphospholipid syndrome; antiphospholipid antibodies; inflammation; immunity; thrombosis; BETA(2)-GLYCOPROTEIN I; CLASSIFICATION CRITERIA; ENDOTHELIAL ACTIVATION; REVISED CRITERIA; DISEASE-ACTIVITY; TISSUE FACTOR; THROMBOSIS; ANTICOAGULANT; PATHOGENESIS; INTERFERON;
D O I
10.3390/ijms252011281
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by an overproduction of cytokines, such as interleukins and interferons, contributing to systemic inflammation and tissue damage. Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disease affecting a third of SLE patients. We performed an in-depth analysis of the available literature, and we highlighted the complex interplay between immunity, inflammation, and thrombosis, the three major pathogenic pathways that are trapped in a mutually reinforcing destructive loop.
引用
收藏
页数:23
相关论文
共 133 条
[1]   β2-Glycoprotein I: a novel component of innate immunity [J].
Agar, Cetin ;
de Groot, Philip G. ;
Morgelin, Matthias ;
Monk, Stephanie D. D. C. ;
van Os, Gwendolyn ;
Levels, Johannes H. M. ;
de Laat, Bas ;
Urbanus, Rolf T. ;
Herwald, Heiko ;
van der Poll, Tom ;
Meijers, Joost C. M. .
BLOOD, 2011, 117 (25) :6939-6947
[2]   Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome [J].
Arachchillage, D. R. J. ;
Efthymiou, M. ;
Mackie, I. J. ;
Lawrie, A. S. ;
Machin, S. J. ;
Cohen, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (11) :1801-1809
[3]   Pathogenesis and management of antiphospholipid syndrome [J].
Arachchillage, Deepa R. J. ;
Laffan, Mike .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (02) :181-195
[4]  
Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1136/annrheumdis-2018-214819, 10.1002/art.40930]
[5]   Association of neutrophil extracellular trap levels with Raynaud's phenomenon, glomerulonephritis and disease index score in SLE patients from Brazil [J].
Auer, Eduardo Delabio ;
Hoch, Valeria Bumiller-Bini ;
Silva, Emiliano Borges da ;
Zonta, Yohan Ricci ;
Dias-Melicio, Luciane Alarcao ;
Skare, Thelma Larocca ;
Picceli, Vanessa F. ;
Messias-Reason, Iara Jose ;
Boldt, Angelica Beate Winter .
IMMUNOBIOLOGY, 2024, 229 (03)
[6]   2023 ACR/EULAR antiphospholipid syndrome classification criteria [J].
Barbhaiya, Medha ;
Zuily, Stephane ;
Naden, Ray ;
Hendry, Alison ;
Manneville, Florian ;
Amigo, Mary-Carmen ;
Amoura, Zahir ;
Andrade, Danieli ;
Andreoli, Laura ;
Artim-Esen, Bahar ;
Atsumi, Tatsuya ;
Avcin, Tadej ;
Belmont, Michael H. ;
Bertolaccini, Maria Laura ;
Branch, D. Ware ;
Carvalheiras, Graziela ;
Casini, Alessandro ;
Cervera, Ricard ;
Cohen, Hannah ;
Costedoat-Chalumeau, Nathalie ;
Crowther, Mark ;
de Jesus, Guilherme ;
Delluc, Aurelien ;
Desai, Sheetal ;
De Sancho, Maria ;
Devreese, Katrien M. ;
Diz-Kucukkaya, Reyhan ;
Duarte-Garcia, Ali ;
Frances, Camille ;
Garcia, David ;
Gris, Jean-Christophe ;
Jordan, Natasha ;
Leaf, Rebecca K. ;
Kello, Nina ;
Knight, Jason S. ;
Laskin, Carl ;
Lee, Alfred I. ;
Legault, Kimberly ;
Levine, Steve R. ;
Levy, Roger A. ;
Limper, Maarten ;
Lockshin, Michael D. ;
Mayer-Pickel, Karoline ;
Musial, Jack ;
Meroni, Pier Luigi ;
Orsolini, Giovanni ;
Ortel, Thomas L. ;
Pengo, Vittorio ;
Petri, Michelle ;
Pons-Estel, Guillermo .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) :1258-1270
[7]   ANTIPHOSPHOLIPID ANTIBODIES, INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR-α IN ATHEROSCLEROTIC PROCESS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS [J].
Bashlakova, N. A. ;
Tyabut, T. D. ;
Buglova, A. E. .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :1063-1064
[8]   Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities? [J].
Belizna, Cristina ;
Stojanovich, Ljudmila ;
Cohen-Tervaert, Jan Willem ;
Fassot, Celine ;
Henrion, Daniel ;
Loufrani, Laurent ;
Nagy, Gyorgy ;
Muchardt, Christian ;
Hasan, Milena ;
Ungeheuer, Marie Noelle ;
Arnaud, Laurent ;
Alijotas-Reig, Jaume ;
Esteve-Valverde, Enrique ;
Nicoletti, Ferdinando ;
Saulnier, Patrick ;
Godon, Alban ;
Reynier, Pascal ;
Chretien, Jean Marie ;
Damian, Laura ;
Omarjee, Loukman ;
Mahe, Guillaume ;
Pistorius, Marc Antoine ;
Meroni, Pier Luigi ;
Devreese, Katrien .
AUTOIMMUNITY REVIEWS, 2018, 17 (08) :739-745
[9]   Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome [J].
Benagiano, Marisa ;
Borghi, Maria Orietta ;
Romagnoli, Jacopo ;
Mahler, Michael ;
Della Bella, Chiara ;
Grassi, Alessia ;
Capitani, Nagaja ;
Emmi, Giacomo ;
Troilo, Arianna ;
Silvestri, Elena ;
Emmi, Lorenzo ;
Alnwaisri, Heba ;
Bitetti, Jacopo ;
Tapinassi, Simona ;
Prisco, Domenico ;
Baldari, Cosima Tatiana ;
Meroni, Pier Luigi ;
D'Elios, Mario Milco .
HAEMATOLOGICA, 2019, 104 (12) :2519-2527
[10]   Innate immune response gene expression profiles characterize primary antiphospholipid syndrome [J].
Bernales, I. ;
Fullaondo, A. ;
Marin-Vidalled, M. J. ;
Ucar, E. ;
Martinez-Taboada, V. ;
Lopez-Hoyos, M. ;
Zubiaga, A. M. .
GENES AND IMMUNITY, 2008, 9 (01) :38-46